Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001415889-25-001953

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BJERKHOLT ERIC · CHIEF FINANCIAL OFFICER

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-21 Grant or award : show line 1 in the form Stock Option (right to buy) +40,000 40,000 D
2025-01-21 Grant or award : show line 2 in the form Restricted Stock Units +10,000 10,000 D
Loading xslF345X05/form4-01232025_100126.xml…